A mobile unit overcomes the challenges to monoclonal antibody infusion for COVID-19 in skilled care facilities.

Sidna Tulledge-ScheitelSarah J BellJennifer J LarsenDennis M BierlePaul TakahashiDarcie E MoehnkeMolly J Destro BorgenDonna J SpringerKaren J ReinschmidtLori J BaumbachJennifer A MatoushAlexander HeyligerSara N HansonRaymund R RazonableRavindra Ganesh

Published in: Journal of the American Geriatrics Society (2021)

The implementation of a mobile infusion unit embedded in a collaborative process resulted in rapid infusion of monoclonal antibodies to high-risk COVID-19 patients in skilled nursing facilities, who would otherwise be unable to access the novel therapies. The therapies were well tolerated and appear beneficial. Further study is warranted to explore the scalability and efficacy of this program.

Keyphrases

quality improvement
monoclonal antibody
sars cov
healthcare
low dose
coronavirus disease
primary care
palliative care
mental health
acute care
pain management